- Home
- PRU vs TAK Comparison
PRU vs TAK Comparison
Compare PRU & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRU
- TAK
- Stock Information
- Founded
- PRU 1875
- TAK 1781
- Country
- PRU United States
- TAK Japan
- Employees
- PRU N/A
- TAK N/A
- Industry
- PRU Life Insurance
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- PRU Finance
- TAK Health Care
- Exchange
- PRU Nasdaq
- TAK Nasdaq
- Market Cap
- PRU 42.4B
- TAK 41.1B
- IPO Year
- PRU N/A
- TAK N/A
- Fundamental
- Price
- PRU $117.63
- TAK $13.05
- Analyst Decision
- PRU Hold
- TAK
- Analyst Count
- PRU 13
- TAK 0
- Target Price
- PRU $127.17
- TAK N/A
- AVG Volume (30 Days)
- PRU 1.3M
- TAK 1.7M
- Earning Date
- PRU 02-04-2025
- TAK 01-30-2025
- Dividend Yield
- PRU 4.43%
- TAK 4.85%
- EPS Growth
- PRU 276.44
- TAK 49.73
- EPS
- PRU 11.26
- TAK 1.27
- Revenue
- PRU $72,966,000,000.00
- TAK $31,732,209,416.00
- Revenue This Year
- PRU N/A
- TAK $6.15
- Revenue Next Year
- PRU N/A
- TAK $0.86
- P/E Ratio
- PRU $10.45
- TAK $20.42
- Revenue Growth
- PRU 45.84
- TAK 9.43
- 52 Week Low
- PRU $100.60
- TAK $12.58
- 52 Week High
- PRU $130.55
- TAK $15.08
- Technical
- Relative Strength Index (RSI)
- PRU 44.19
- TAK 40.02
- Support Level
- PRU $113.62
- TAK $12.86
- Resistance Level
- PRU $121.24
- TAK $13.45
- Average True Range (ATR)
- PRU 2.04
- TAK 0.13
- MACD
- PRU 0.03
- TAK -0.00
- Stochastic Oscillator
- PRU 52.56
- TAK 32.20
About PRU Prudential Financial Inc.
Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 10% of its earnings and has around $1.3 trillion in assets under management. The US businesses are responsible for about 50% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.